UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis

Neurology, 2002-06, Vol.58 (11), p.1652-1659

2002

Volltextzugriff (PDF)

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

The Lancet (British edition), 2008-12, Vol.372 (9656), p.2115-2123

2008

Volltextzugriff (PDF)

P.027 Efficacy and Safety of Eptinezumab Initiated During a Migraine Attack: Results from the RELIEF Study

Canadian journal of neurological sciences, 2021-11, Vol.48 (s3), p.S27-S28

2021

Volltextzugriff (PDF)

Vascular safety of erenumab for migraine prevention

Neurology, 2020-06, Vol.94 (23), p.1052-1052

2020

Volltextzugriff (PDF)

Age Effects on Placebo Response Rates in Clinical Trials of Acute Agents for Migraine: Pooled Analysis of Rizatriptan Trials in Adults

Cephalalgia, 2009-07, Vol.29 (7), p.711-718

2009

Volltextzugriff (PDF)

Comparative Efficacy of Eletriptan 40 mg Versus Sumatriptan 100 mg

Headache, 2003-03, Vol.43 (3), p.214-222

2003

Volltextzugriff (PDF)

Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraine

Neurology, 2004-05, Vol.62 (9), p.1552-1557

2004

Volltextzugriff (PDF)

Multicenter prospective evaluation of proposed pediatric migraine revisions to the IHS criteria

Headache, 1997-10, Vol.37 (9), p.545-548

1997

Volltextzugriff (PDF)

Efficacy of Zolmitriptan Nasal Spray for the Treatment of Acute Migraine in Adolescents: Subgroup analysis by Age (S52.005)

Neurology, 2017, Vol.88 (16_supplement)

2017

Volltextzugriff (PDF)

Chronic Daily Headache Prophylaxis With Tizanidine: A Double-Blind, Placebo-Controlled, Multicenter Outcome Study

Headache, 2002-06, Vol.42 (6), p.470-482

2002

Volltextzugriff (PDF)

Nasal Delivery of Antimigraine Drugs: Clinical Rationale and Evidence Base

Headache, 2006-11, Vol.46 (s4), p.S192-S201

2006

Volltextzugriff (PDF)

An Open-Label Dose-Titration Study of the Efficacy and Tolerability of Tizanidine Hydrochloride Tablets in the Prophylaxis of Chronic Daily Headache

Headache, 2001-04, Vol.41 (4), p.357-368

2001

Volltextzugriff (PDF)

Triptans for Migraine Management in Adolescents

Headache, 2002-07, Vol.42 (7), p.675-679

Winner, Paul

2002

Volltextzugriff (PDF)

Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg : A pooled analysis of data from six clinical trials

Clinical therapeutics, 2005-11, Vol.27 (11), p.1785-1794

2005

Volltextzugriff (PDF)

Sumatriptan Nasal Spray in Adolescent Migraineurs: A Randomized, Double-Blind, Placebo-Controlled, Acute Study

Headache, 2006-02, Vol.46 (2), p.212-222

2006

Volltextzugriff (PDF)

OnabotulinumtoxinA is well tolerated in chronic migraine patients taking oral preventive medications: Long-term compel analysis by treatment cycle

Toxicon (Oxford), 2018-12, Vol.156, p.S114-S114

2018

Volltextzugriff (PDF)

Pain-Free Results With Sumatriptan Taken at the First Sign of Migraine Pain: 2 Randomized, Double-Blind, Placebo-Controlled Studies

Mayo Clinic proceedings, 2003-10, Vol.78 (10), p.1214-1222

2003

Volltextzugriff (PDF)

Rizatriptan 5 mg for the Acute Treatment of Migraine in Adolescents: Results From a Double-Blind, Single-Attack Study and Two Open-Label, Multiple-Attack Studies

Headache, 2004-10, Vol.44 (9), p.891-899

2004

Volltextzugriff (PDF)

Migraine Preventive Medication Reduces Resource Utilization

Headache, 2003-03, Vol.43 (3), p.171-178

2003

Volltextzugriff (PDF)

Migraine: diagnosis and rational treatment

International journal of fertility & women's medicine, 1998-03, Vol.43 (2), p.104

Winner, P K

1998

Volltextzugriff (PDF)

The Long-term Tolerability and Efficacy of Oral Zolmitriptan (Zomig, 31X90) in the Acute Treatment of Migraine. An International Study

Headache, 1998-03, Vol.38 (3), p.173-183

Cady, Roger K.

1998

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age

Neuropediatrics, 2008, Vol.39 (1)

2008

Volltextzugriff (PDF)

A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine

Archives of neurology (Chicago), 1996-02, Vol.53 (2), p.180-184

1996

Volltextzugriff (PDF)

Development and Validation of the Headache Needs Assessment (HANA) Survey

Headache, 2001-04, Vol.41 (4), p.402-409

2001

Volltextzugriff (PDF)

Comparison of therapeutic gain with therapeutic ratio for the assessment of selective 5HT(1B/1D) agonist efficacy in migraine

Headache, 2002-07, Vol.42 (7), p.680-688

2002

Volltextzugriff (PDF)

1 – 25 von 211

Suche als RSS-Feed

Aktive Filter

ThemaChild

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(173)
Mit Volltextzugriff
(159)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(102)
Life Sciences & Biomedicine
(90)
Humans
(63)
Biological And Medical Sciences
(48)
Male
(42)
Female
(41)
Medical Sciences
(34)
Neurosciences & Neurology
(34)
Clinical Neurology
(31)
Adult
(26)
Middle Aged
(23)
Adolescent
(21)
Aged
(21)
Migraine Disorders - Drug Therapy
(21)
Pharmacology. Drug Treatments
(21)
Animals
(19)
Neurology
(19)
Migraine
(17)
Social Sciences
(15)
Fundamental And Applied Biological Sciences. Psychology
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

P.027 Efficacy and Safety of Eptinezumab Initiated During a Migraine Attack: Results from the RELIEF Study

Vascular safety of erenumab for migraine prevention

Age Effects on Placebo Response Rates in Clinical Trials of Acute Agents for Migraine: Pooled Analysis of Rizatriptan Trials in Adults

Comparative Efficacy of Eletriptan 40 mg Versus Sumatriptan 100 mg

Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraine

Multicenter prospective evaluation of proposed pediatric migraine revisions to the IHS criteria

Efficacy of Zolmitriptan Nasal Spray for the Treatment of Acute Migraine in Adolescents: Subgroup analysis by Age (S52.005)

Chronic Daily Headache Prophylaxis With Tizanidine: A Double-Blind, Placebo-Controlled, Multicenter Outcome Study

Nasal Delivery of Antimigraine Drugs: Clinical Rationale and Evidence Base

An Open-Label Dose-Titration Study of the Efficacy and Tolerability of Tizanidine Hydrochloride Tablets in the Prophylaxis of Chronic Daily Headache

Triptans for Migraine Management in Adolescents

Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg : A pooled analysis of data from six clinical trials

Sumatriptan Nasal Spray in Adolescent Migraineurs: A Randomized, Double-Blind, Placebo-Controlled, Acute Study

OnabotulinumtoxinA is well tolerated in chronic migraine patients taking oral preventive medications: Long-term compel analysis by treatment cycle

Pain-Free Results With Sumatriptan Taken at the First Sign of Migraine Pain: 2 Randomized, Double-Blind, Placebo-Controlled Studies

Rizatriptan 5 mg for the Acute Treatment of Migraine in Adolescents: Results From a Double-Blind, Single-Attack Study and Two Open-Label, Multiple-Attack Studies

Migraine Preventive Medication Reduces Resource Utilization

Migraine: diagnosis and rational treatment

The Long-term Tolerability and Efficacy of Oral Zolmitriptan (Zomig, 31X90) in the Acute Treatment of Migraine. An International Study

A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age

A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine

Development and Validation of the Headache Needs Assessment (HANA) Survey

Comparison of therapeutic gain with therapeutic ratio for the assessment of selective 5HT(1B/1D) agonist efficacy in migraine

Aktive Filter

Suchergebnisse filtern